@article{article, title = {{Dupilumab provides clinically meaningful responses in children aged 6鈥�11 years with severe atopic dermatitis: post hoc analysis results from a phase III trial}},
publisher = {{Springer Science and Business Media LLC}},
url = {{https://eprints.whiterose.ac.uk/id/eprint/202963 }},
year = {{2023}},
month = {{6}},
author = {{Siegfried EC and Cork MJ and Katoh N and Zhang H and Chuang C-C and Thomas RB and Rossi AB and Cyr SL and Zhang A}},
doi = {{10.1007/s40257-023-00791-7}},
volume = {{24}},
journal = {{American Journal of Clinical Dermatology}},
issue = {{5}},
pages = {{787-798}},
note = {{Accessed on 2025/01/02}}}